141 related articles for article (PubMed ID: 6628373)
1. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.
Gemmell CG; Peterson PK; Schmeling D; Mathews J; Quie PG
Eur J Clin Microbiol; 1983 Aug; 2(4):327-34. PubMed ID: 6628373
[TBL] [Abstract][Full Text] [Related]
2. Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.
Namavar F; Kaan JA; Verweij-van Vught AM; Vel WA; Bal M; Kester AD; MacLaren DM
Eur J Clin Microbiol; 1986 Jun; 5(3):324-9. PubMed ID: 3527702
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations.
Veringa EM; Lambe DW; Ferguson DA; Verhoef J
J Antimicrob Chemother; 1989 Apr; 23(4):577-87. PubMed ID: 2745261
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of phagocytosis of Bacteroides fragilis following incubation with clindamycin.
Howard RJ; Soucy DM
J Antimicrob Chemother; 1983 Oct; 12 Suppl C():63-8. PubMed ID: 6643342
[TBL] [Abstract][Full Text] [Related]
5. Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.
Veringa EM; Verhoef J
Chemotherapy; 1987; 33(4):243-9. PubMed ID: 3608624
[TBL] [Abstract][Full Text] [Related]
6. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria.
Wade BH; Kasper DL; Mandell GL
J Antimicrob Chemother; 1983 Oct; 12 Suppl C():51-62. PubMed ID: 6643341
[TBL] [Abstract][Full Text] [Related]
7. Clindamycin and its action on the susceptibility of pathogenic bacteria to phagocytosis.
Gemmell CG
Scand J Infect Dis Suppl; 1984; 43():17-23. PubMed ID: 6398907
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.
Gemmell CG; Peterson PK; Schmeling D; Kim Y; Mathews J; Wannamaker L; Quie PG
J Clin Invest; 1981 May; 67(5):1249-56. PubMed ID: 7014632
[TBL] [Abstract][Full Text] [Related]
9. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide.
Simon GL; Klempner MS; Kasper DL; Gorbach SL
J Infect Dis; 1982 Jan; 145(1):72-7. PubMed ID: 7054319
[TBL] [Abstract][Full Text] [Related]
10. Clindamycin enhances opsonization of Staphylococcus aureus.
Milatovic D; Braveny I; Verhoef J
Antimicrob Agents Chemother; 1983 Sep; 24(3):413-7. PubMed ID: 6638997
[TBL] [Abstract][Full Text] [Related]
11. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.
Bjornson AB; Bjornson HS; Kitko BP
Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104
[TBL] [Abstract][Full Text] [Related]
12. Effects of Bacteroides asaccharolyticus cells and B. fragilis surface components on serum opsonisation and phagocytosis.
Jones GR; Gemmell CG
J Med Microbiol; 1986 Nov; 22(3):225-9. PubMed ID: 3534273
[TBL] [Abstract][Full Text] [Related]
13. The role of glycocalyx in surface phagocytosis of Bacteroides spp., in the presence and absence of clindamycin.
Veringa EM; Ferguson DA; Lambe DW; Verhoef J
J Antimicrob Chemother; 1989 May; 23(5):711-20. PubMed ID: 2474527
[TBL] [Abstract][Full Text] [Related]
14. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
16. Interactions of polymorphonuclear leukocytes with anaerobic bacteria.
Klempner MS
Rev Infect Dis; 1984; 6 Suppl 1():S40-4. PubMed ID: 6372036
[TBL] [Abstract][Full Text] [Related]
17. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.
Zaleznik DF; Zhang ZL; Onderdonk AB; Kasper DL
J Infect Dis; 1986 Jul; 154(1):40-6. PubMed ID: 3711690
[TBL] [Abstract][Full Text] [Related]
18. Effects of subinhibitory concentrations of clindamycin on the morphological, biochemical and genetic characteristics of Bacteroides fragilis.
Silvestro EM; Nakano V; Arana-Chavez VE; Marques MV; Avila-Campos MJ
FEMS Microbiol Lett; 2006 Apr; 257(2):189-94. PubMed ID: 16553852
[TBL] [Abstract][Full Text] [Related]
19. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis.
Reid JH; Patrick S
J Med Microbiol; 1984 Jun; 17(3):247-57. PubMed ID: 6726784
[TBL] [Abstract][Full Text] [Related]
20. Trospectomycin enhances surface phagocytosis of Bacteroides and Staphylococcus by altering the bacterial glycocalyx.
Veringa EM; Ferguson DA; Lambe DW; Verhoef J
Zentralbl Bakteriol; 1989 Sep; 271(3):311-20. PubMed ID: 2529862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
